CerSci Therapeutics Competitors and Similar CompaniesClear all

Novartis's competitors and similar companies include Pfizer and Chengdu Push Bio-technology.

	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Chengdu Push Bio-technology Chengdu Push Bio-technology (成都普思生物科技股份有限公司) is a provider of separation and purification of natural medicines and pharmaceutical research services.
Founding Date	Founding Date 1996	Founding Date 1849	Founding Date 2005
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Cheng Du Shi, CN HQ
Employees	Employees 75,883	Employees 81,0008% decrease	Employees N/A
Financial
Revenue (est.)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $62.6b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $8.4b (FY, 2025)	Cost of goods $16.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $49.8b (FY, 2025)	Gross profit $46.5b (FY, 2025)	Gross profit N/A
Net income	Net income $14b (FY, 2025)	Net income $7.8b (FY, 2025)	Net income N/A
Operating ⚠
Phase III Trials Products	Phase III Trials Products 44 (FY, 2022)	Phase III Trials Products 32 (FY, 2024)	Phase III Trials Products N/A
Registration Phase Products	Registration Phase Products 8 (FY, 2022)	Registration Phase Products 5 (FY, 2024)	Registration Phase Products N/A